This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Harrison-Read, P.E. Articles by File, S.E. Search for Related Content PubMed Articles by Harrison-Read, P.E. Articles by File, S.E. Social Bookmarking                         What's this?

Flumazenil-precipitated panic and dysphoria in patients dependent on benzodiazepines: a possible aid to abstinence

Academic Unit of Psychiatry, St Charles Hospital, Exmoor Street, London W10 6DZ

P. Tyrer

Academic Unit of Psychiatry, St Charles Hospital, Exmoor Street, London W10 6DZ

C. Lawson

Northern General Hospital, Sheffield S5 7AU

S. Lack

Academic Unit of Psychiatry, St Charles Hospital, Exmoor Street, London W10 6DZ

C. Fernandes

Psychopharmacology Research Unit, UMDS Division of Pharmacology, Guy's Hospital, London SE1 9RT, UK

S.E. File

Psychopharmacology Research Unit, UMDS Division of Pharmacology, Guy's Hospital, London SE1 9RT, UK

Ten long-term users of benzodiazepines (average daily dose, 20 mg of diazepam or equivalent) who had experienced problems in withdrawing from the drugs were given an i.v. challenge with either the benzodiazepine antagonist flumazenil (1 mg injected over 30 s) or placebo (vehicle solution) in a randomized double-blind design. There were no 'pseudo withdrawal' responses to either single-blind or double-blind placebo injections, whereas flumazenil produced dramatic panic reactions in all four subjects tested, followed by characteristic benzodiazepine withdrawal symptoms. There were also small but significant rises in pulse rate and blood pressure, but no change in serum cortisol. Flumazenil-induced panic could not be entirely accounted for by a past or present diagnosis of panic disorder, and did not seem to be related to previous withdrawal problems, present benzodiazepine dosage, or to the severity of withdrawal symptoms precipitated by flumazenil in the same challenge test. Attempts to reduce benzodiazepine intake over the next 3 weeks tended to be more successful in the flumazenil group. The results are discussed with reference to possible changes in the GABA-benzodiazepine system in long-term benzodiazepine users.

Key Words: flumazenil • benzodiazepine withdrawal • flumazenil-induced panic • long-term benzodiazepine users

Journal of Psychopharmacology, Vol. 10, No. 2, 89-97 (1996)
DOI: 10.1177/026988119601000201


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S Hood, G O'Neil, and G Hulse The role of flumazenil in the treatment of benzodiazepine dependence: physiological and psychological profiles J Psychopharmacol, June 1, 2009; 23(4): 401 - 409. [Abstract] [PDF]

				D. J. Nutt Death and Dependence: Current Controversies over the Selective Serotonin Reuptake Inhibitors J Psychopharmacol, December 1, 2003; 17(4): 355 - 364. [Abstract] [PDF]